FDA Gives Defibtech Clearance to Market AEDs

FDA Gives Defibtech Clearance to Market AEDs

GUILFORD, CT
June 19, 2002

The U.S. Food and Drug Administration (FDA) has granted Defibtech LLC 510(k) clearance to market its new line of Automated External Defibrillators (AEDs). Defibtech's AEDs will be marketed under the Lifeline and Reviver names. These products were developed by a team of physicians and engineers with extensive experience not only in the medical device field, but also in high-volume consumer products. Defibtech's AEDs integrate the latest electronic technology in a package with best-in-class features and at a revolutionary price.

Standard features include: biphasic defibrillation technology, self-testing capability, class leading user interface and voice prompts, longest operational battery life (up to 7 years), and a professional-grade rugged design. Even with this industry leading feature set, the Defibtech AED is the value leader with a Manufacturer's Suggested Retail Price (MSRP) at $1,495. This price includes everything a customer needs to completely deploy this lifesaving solution, including the AED, defibrillation pads and a 5-year 125-shock battery pack.